• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于治疗人腹膜后脂肪肉瘤的新型IWS1抑制剂的分子对接和生物学评价

Molecular docking and biological evaluation of a novel IWS1 inhibitor for the treatment of human retroperitoneal liposarcoma.

作者信息

Goryunova Marina, He Yiran, Karakis Carson, Titerina Elizaveta K, Salazar-Puerta Ana I, Tahara Sayumi, Sp Nipin, Thakkar Neil N, Cómbita-Heredia Orlando, Dathathreya Kavya, La Ferlita Alessandro, Xu Yanping, Zhang Zhentao, Pollock Raphael, Gallego-Perez Daniel, Zhu Hua, Hadad Christopher M, Beane Joal D

机构信息

Department of Surgery, Division of Surgical Oncology, The James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.

Department of Chemistry and Biochemistry, The Ohio State University, Columbus, OH, USA.

出版信息

Sci Rep. 2025 Jul 2;15(1):22965. doi: 10.1038/s41598-025-07215-y.

DOI:10.1038/s41598-025-07215-y
PMID:40594510
Abstract

IWS1 is a key assembly factor of the RNA polymerase II (RNAPII) elongation complex, and its overexpression is associated with worse outcomes in patients with liposarcoma (LPS). This study aimed to identify compounds that can disrupt the IWS1/Spt6 interaction and assess their biological effects in dedifferentiated LPS (DDLPS). Using the AlphaFold-predicted structure of IWS1, we identified a core binding region (AA 545-694) for its interaction with Spt6. Through molecular modeling and virtual screening, Ketotifen and Desloratadine were predicted as candidate inhibitors. Both were predicted to mimic Spt6 phenylalanine (F217) and disrupt the complex, which was confirmed by co-immunoprecipitation. Functional assays showed that treatment with either compound reduced migration, invasion, and spheroid formation in DDLPS cell lines. Additionally, increased nuclear localization of IWS1 was observed. These findings suggest Ketotifen and Desloratadine as promising inhibitors of the IWS1/Spt6 interaction, with potential applications in reducing the invasive properties of human LPS.

摘要

IWS1是RNA聚合酶II(RNAPII)延伸复合物的关键组装因子,其过表达与脂肪肉瘤(LPS)患者的不良预后相关。本研究旨在鉴定能够破坏IWS1/Spt6相互作用的化合物,并评估它们在去分化脂肪肉瘤(DDLPS)中的生物学效应。利用AlphaFold预测的IWS1结构,我们确定了其与Spt6相互作用的核心结合区域(氨基酸545 - 694)。通过分子建模和虚拟筛选,预测酮替芬和地氯雷他定为候选抑制剂。两者均被预测可模拟Spt6苯丙氨酸(F217)并破坏复合物,这通过免疫共沉淀得到证实。功能分析表明,用这两种化合物处理均可降低DDLPS细胞系的迁移、侵袭和球体形成。此外,还观察到IWS1的核定位增加。这些发现表明酮替芬和地氯雷他定是IWS1/Spt6相互作用的有前景的抑制剂,在降低人类LPS的侵袭特性方面具有潜在应用价值。

相似文献

1
Molecular docking and biological evaluation of a novel IWS1 inhibitor for the treatment of human retroperitoneal liposarcoma.一种用于治疗人腹膜后脂肪肉瘤的新型IWS1抑制剂的分子对接和生物学评价
Sci Rep. 2025 Jul 2;15(1):22965. doi: 10.1038/s41598-025-07215-y.
2
Molecular feature-based classification of retroperitoneal liposarcoma: a prospective cohort study.基于分子特征的腹膜后脂肪肉瘤分类:一项前瞻性队列研究。
Elife. 2025 May 23;14:RP100887. doi: 10.7554/eLife.100887.
3
Nuclear factor IA-mediated transcriptional regulation of crystallin αB inhibits hepatocellular carcinoma progression.核因子IA介导的晶状体蛋白αB转录调控抑制肝细胞癌进展。
Mol Clin Oncol. 2025 Jun 20;23(2):72. doi: 10.3892/mco.2025.2867. eCollection 2025 Aug.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
Correlation of senescence-related gene FEN1 on neuroblastoma progression and cisplatin chemotherapy sensitivity.衰老相关基因FEN1与神经母细胞瘤进展及顺铂化疗敏感性的相关性
Oncol Res. 2025 Jun 26;33(7):1695-1708. doi: 10.32604/or.2025.060021. eCollection 2025.
7
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.肺炎球菌结合疫苗的免疫原性和血清效力:系统评价和网络荟萃分析。
Health Technol Assess. 2024 Jul;28(34):1-109. doi: 10.3310/YWHA3079.
8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.

本文引用的文献

1
Recurrence of locally invasive retroperitoneal dedifferentiated liposarcoma shortly after surgery: A case report and literature review.术后短期内局部侵袭性腹膜后去分化脂肪肉瘤复发:病例报告及文献复习。
Medicine (Baltimore). 2024 Mar 29;103(13):e37604. doi: 10.1097/MD.0000000000037604.
2
Comparison of three-dimensional cell culture techniques of dedifferentiated liposarcoma and their integration with future research.去分化脂肪肉瘤的三维细胞培养技术比较及其与未来研究的整合
Front Cell Dev Biol. 2024 Mar 4;12:1362696. doi: 10.3389/fcell.2024.1362696. eCollection 2024.
3
Well-differentiated liposarcomas and dedifferentiated liposarcomas: Systemic treatment options for two sibling neoplasms.
高分化脂肪肉瘤和去分化脂肪肉瘤:两种同胞性肿瘤的系统治疗选择。
Cancer Treat Rev. 2024 Apr;125:102716. doi: 10.1016/j.ctrv.2024.102716. Epub 2024 Mar 11.
4
Quantification of Binding of Small Molecules to Native Proteins Overexpressed in Living Cells.活细胞中表达的天然蛋白质与小分子结合的定量。
J Am Chem Soc. 2024 Jan 10;146(1):187-200. doi: 10.1021/jacs.3c07488. Epub 2023 Dec 20.
5
MDM2-p53 in liposarcoma: The need for targeted therapies with novel mechanisms of action.脂肪肉瘤中的MDM2-p53:对具有新型作用机制的靶向治疗的需求。
Cancer Treat Rev. 2024 Jan;122:102668. doi: 10.1016/j.ctrv.2023.102668. Epub 2023 Dec 10.
6
Retroperitoneal Soft Tissue Sarcoma: Emerging Therapeutic Strategies.腹膜后软组织肉瘤:新兴治疗策略
Cancers (Basel). 2023 Nov 18;15(22):5469. doi: 10.3390/cancers15225469.
7
Preclinical Testing Techniques: Paving the Way for New Oncology Screening Approaches.临床前检测技术:为新的肿瘤筛查方法铺平道路。
Cancers (Basel). 2023 Sep 7;15(18):4466. doi: 10.3390/cancers15184466.
8
Treatment of De-Differentiated Liposarcoma in the Era of Immunotherapy.免疫治疗时代去分化脂肪肉瘤的治疗。
Int J Mol Sci. 2023 May 31;24(11):9571. doi: 10.3390/ijms24119571.
9
Phosphorylation of IWS1 by AKT maintains liposarcoma tumor heterogeneity through preservation of cancer stem cell phenotypes and mesenchymal-epithelial plasticity.AKT介导的IWS1磷酸化通过维持癌症干细胞表型和间充质-上皮可塑性来保持脂肪肉瘤的肿瘤异质性。
Oncogenesis. 2023 May 26;12(1):30. doi: 10.1038/s41389-023-00469-z.
10
The conserved histone chaperone Spt6 is strongly required for DNA replication and genome stability.保守的组蛋白伴侣 Spt6 强烈需要 DNA 复制和基因组稳定性。
Cell Rep. 2023 Mar 28;42(3):112264. doi: 10.1016/j.celrep.2023.112264. Epub 2023 Mar 15.